Jennerex products kill cancer by targeting, attacking and eradicating cancer cells:
Targeting - Jennerex products have been genetically engineered to be active and multiply in the presence of mutations and genetic pathway activations commonly found in the majority of solid cancer types but not in normal cells. Solid tumors are vulnerable to attack and fertile soil for our products to replicate and attack the tumor mass.
Attacking - Targeted virus replication turns cancer cells into therapeutic factories generating thousands of new therapeutic copies which results in the cancer cells exploding (oncolysis) and releasing the new therapeutic copies to target the adjacent cancer cells in the tumor mass. Therapeutic copies also spread within the body to target and attack distant tumor sites.
Eradicating - The primary replication and cancer cell explosion activate a cascade of anti-tumor immune response and blood supply shutdown. In addition, our products express a therapeutic payload simultaneously; these payloads act in concert with the primary oncolysis mechanism to eradicate cancer by multiple mechanisms simultaneously. The result is that tumors are eradicated by a multi-pronged attack.